Literature DB >> 26427512

Degradation of miR-21 induces apoptosis and inhibits cell proliferation in human hepatocellular carcinoma.

Z Najafi1, M Sharifi2, G Javadi1.   

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs, 18-25 nucleotides long and have an important role in post-transcriptional regulation of gene. Several aspects of cellular activities such as cell growth, proliferation and differentiation are regulated by miRNAs. In many cancers and malignancies, up- or downregulation of different miRNAs has been reported. In human hepatocellular carcinoma (HCC), upregulation of miR-21 has been reported in human in vitro studies. Here, we made an assessment of the effect of miR-21 degradation on viability and apoptosis of HCC cell line (HepG2) using locked nucleic acid (LNA). At different time points (24, 48, 72 h) after LNA-anti-miR-21 transfection, 3-[4,5-dimethylthiazol-2-yl]-2, 5-diphenyl tetrazolium bromide assay and Annexin/propidium iodide staining were performed. The results show that miR-21 degradation can decrease the viability of cells, mainly by induction of apoptosis and necrosis. These findings suggest that degradation of miR-21 could be used as a novel approach in treatment of HCC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26427512     DOI: 10.1038/cgt.2015.51

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  35 in total

1.  LNA-modified oligonucleotides mediate specific inhibition of microRNA function.

Authors:  Ulf Andersson Ørom; Sakari Kauppinen; Anders H Lund
Journal:  Gene       Date:  2006-02-24       Impact factor: 3.688

2.  The PDCD4/miR-21 pathway in medullary thyroid carcinoma.

Authors:  Gianmaria Pennelli; Francesca Galuppini; Susi Barollo; Elisabetta Cavedon; Loris Bertazza; Matteo Fassan; Vincenza Guzzardo; Maria Rosa Pelizzo; Massimo Rugge; Caterina Mian
Journal:  Hum Pathol       Date:  2014-10-02       Impact factor: 3.466

3.  An extensive class of small RNAs in Caenorhabditis elegans.

Authors:  R C Lee; V Ambros
Journal:  Science       Date:  2001-10-26       Impact factor: 47.728

4.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21.

Authors:  Frederick J Sheedy; Eva Palsson-McDermott; Elizabeth J Hennessy; Cara Martin; John J O'Leary; Qingguo Ruan; Derek S Johnson; Youhai Chen; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2009-11-29       Impact factor: 25.606

Review 5.  MicroRNAs as anti-cancer therapy.

Authors:  Michela Garofalo; Gianpiero Di Leva; Carlo M Croce
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 6.  MicroRNAs: novel regulators in the hallmarks of human cancer.

Authors:  Kai Ruan; Xiaoguang Fang; Gaoliang Ouyang
Journal:  Cancer Lett       Date:  2009-05-22       Impact factor: 8.679

7.  MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.

Authors:  Shoumei Bai; Mohd W Nasser; Bo Wang; Shu-Hao Hsu; Jharna Datta; Huban Kutay; Arti Yadav; Gerard Nuovo; Pawan Kumar; Kalpana Ghoshal
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

8.  Management of hepatocellular carcinoma: an update.

Authors:  Jordi Bruix; Morris Sherman
Journal:  Hepatology       Date:  2011-03       Impact factor: 17.425

9.  Exosomal miRNAs: Biological Properties and Therapeutic Potential.

Authors:  Guoku Hu; Kristen M Drescher; Xian-Ming Chen
Journal:  Front Genet       Date:  2012-04-20       Impact factor: 4.599

10.  Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells.

Authors:  Yoshimasa Saito; Jeffrey M Friedman; Yoshitomo Chihara; Gerda Egger; Jody C Chuang; Gangning Liang
Journal:  Biochem Biophys Res Commun       Date:  2008-12-29       Impact factor: 3.322

View more
  16 in total

1.  In Vitro Anti-hepatoma Activities of Notoginsenoside R1 Through Downregulation of Tumor Promoter miR-21.

Authors:  Yuan Li; Zhong Li; Yunhao Jia; Bo Ding; Jinsong Yu
Journal:  Dig Dis Sci       Date:  2019-09-26       Impact factor: 3.199

2.  Blockage of miR-92a-3p with locked nucleic acid induces apoptosis and prevents cell proliferation in human acute megakaryoblastic leukemia.

Authors:  M Sharifi; R Salehi
Journal:  Cancer Gene Ther       Date:  2015-12-11       Impact factor: 5.987

Review 3.  Exosomes in liver pathology.

Authors:  Keisaku Sato; Fanyin Meng; Shannon Glaser; Gianfranco Alpini
Journal:  J Hepatol       Date:  2016-03-14       Impact factor: 25.083

4.  LNA Inhibitor in microRNA miR-23b as a Potential Anti-proliferative Option in Human Hepatocellular Carcinoma.

Authors:  Zoya Najafi; Mohammadreza Sharifi; Gholamreza Javadi
Journal:  J Gastrointest Cancer       Date:  2020-03

5.  Locked nucleic acid anti-miR-21 inhibits cell growth and invasive behaviors of a colorectal adenocarcinoma cell line: LNA-anti-miR as a novel approach.

Authors:  R Nedaeinia; M Sharifi; A Avan; M Kazemi; L Rafiee; M Ghayour-Mobarhan; R Salehi
Journal:  Cancer Gene Ther       Date:  2016-07-01       Impact factor: 5.987

6.  Long noncoding RNA CNALPTC1 promotes cell proliferation and migration of papillary thyroid cancer via sponging miR-30 family.

Authors:  Cunrong Chen; Lili Zhou; Hui Wang; Junnian Chen; Wen Li; Wei Liu; Mingjie Shen; Hongzhou Liu; Xiaomin Fu
Journal:  Am J Cancer Res       Date:  2018-01-01       Impact factor: 6.166

Review 7.  Dairy consumption and hepatocellular carcinoma risk.

Authors:  Bodo C Melnik
Journal:  Ann Transl Med       Date:  2021-04

8.  Klf4 inhibits tumor growth and metastasis by targeting microRNA-31 in human hepatocellular carcinoma.

Authors:  Chuan Tian; Shanshan Yao; Li Liu; Youcheng Ding; Qingwang Ye; Xiao Dong; Yong Gao; Ning Yang; Qi Li
Journal:  Int J Mol Med       Date:  2016-11-24       Impact factor: 4.101

Review 9.  Targeting MicroRNAs in Cancer Gene Therapy.

Authors:  Weidan Ji; Bin Sun; Changqing Su
Journal:  Genes (Basel)       Date:  2017-01-09       Impact factor: 4.096

Review 10.  Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs.

Authors:  Dinh-Duc Nguyen; Suhwan Chang
Journal:  Int J Mol Sci       Date:  2017-12-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.